07.01.2013 Views

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

FMMS<br />

91939<br />

ME2MS<br />

89284<br />

1 0.35-0.69 Equivocal<br />

2 0.70-3.49 Positive<br />

3 3.50-17.4 Positive<br />

4 17.5-49.9 Strongly positive<br />

5 50.0-99.9 Strongly positive<br />

6 > or =100 Strongly positive Reference values<br />

apply to all ages.<br />

Clinical References: Homburger HA: Allergic diseases. In Clinical Diagnosis and Management by<br />

Laboratory Methods. 21st edition. Edited by McPherson RA, Pincus MR. WB Saunders, Publ, New York,<br />

Chapter 53, Part VI, pp. 961-971, 2007<br />

Meconium Methadone Screen<br />

Reference Values:<br />

The specimen was screened by Immunoassay at the following<br />

threshold concentrations.<br />

Methadone: 300 ng/gm<br />

Positive results are confirmed by Gas Chromatography with<br />

Mass Spectrometry (GC/MS) to limit of detection.<br />

<strong>Test</strong> Performed by: Medtox Laboratories, Inc.<br />

402 W County Road D<br />

St. Paul, MN 55112<br />

MECP2 Gene, Full Gene Analysis<br />

Clinical Information: Methyl-CpG-binding protein 2 (MeCP2) is a transcriptional repressor<br />

protein encoded by the MECP2 gene located on the X chromosome. Genetic mutations in MECP2 alter<br />

the expression of targeted genes and can be associated with variable phenotypes in females including<br />

classic Rett syndrome, variant or atypical Rett syndrome, mild mental retardation, and asymptomatic<br />

carriers. Males with MECP2 mutations can present with variable phenotypes as well. The variability in<br />

males can, in part, be attributed to the type of MECP2 mutation present; point mutations are typically<br />

associated with severe neonatal encephalopathy and gene duplications are associated with MECP2<br />

duplication syndrome. Full MECP2 gene analysis via sequencing and large duplication/deletion studies<br />

has been useful in identifying germline mutations in individuals with these clinical presentations. Rett<br />

Syndrome Rett syndrome is an X-linked, panethnic condition with an incidence of approximately<br />

1/8,500 to 1/15,000 females. Disease course typically begins after 6 to 18 months of apparently normal<br />

development with rapid regression in language and motor skills. A hallmark feature of this condition is<br />

repetitive, stereotyped hand movements, sometimes described as hand-wringing. Clinical criteria have<br />

been established for diagnosis of classic and atypical or variant Rett syndrome. Greater than 88% of<br />

females with a clinical diagnosis of classic Rett syndrome demonstrate a mutation by this test. The<br />

detection rate is approximately 43% for females with a clinical diagnosis of atypical or variant Rett<br />

syndrome. For individuals in which there is clinical suspicion for Rett syndrome but clinical criteria are<br />

not met, the detection rate is lower given the phenotypic overlap with other conditions (eg, Angelman<br />

syndrome). Nonrandom X chromosome inactivation, resulting in phenotypic variability within families,<br />

has been reported in females with MECP2 mutations. Although 99.5% of mutations associated with Rett<br />

syndrome are de novo, asymptomatic or very mildly affected carrier mothers of classically affected<br />

daughters have been reported. Genetic counseling should be provided with this, and the possibility of<br />

germline or somatic mosaicism, in mind. MECP2 Duplication Syndrome Although MECP2 mutations<br />

Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong>Laboratories.com Page 1173

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!